Skip to main
University-wide Navigation

College of Pharmacy Receives $11.8 Million to Further Substance Use Disorder Research

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

COVID-19 Vaccine Candidate Tested at UK Shows Positive Preclinical Results

PDS0203 stands out among COVID-19 vaccines currently in development because it includes a vaccine technology pioneered by PDS Biotech called Versamune®, which stimulates important parts of the immune system to activate T cells.

UK Part of Nationally Unique Partnership to Commercialize Tech Innovations

“We all want to grow Kentucky’s tech sector and create the high-paying, knowledge-based jobs that follow. A big part of doing so is turning Kentucky’s own academic research and development capabilities into commercially viable products and startups.”

NIH-funded Network Led by XLerateHealth and UK Supports HBCU Commercialization

Supported by XLerateHealth, a health care startup accelerator in Louisville, Kentucky, and by UK, EnRICH is an outgrowth of NIH funding UK received in October 2018 — $3.5 million over three years — to create the XLerator Network.

Artemisia Annua Could Be Promising Treatment for COVID-19

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

UK, ArtemiLife Partner to Test for Anti-Cancer Activity of Artemisia Annua Extracts

UK and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

UK, Lexmark Form Technology Partnership

UK's Office of Technology Commercialization announces its first-ever license agreement with Lexmark International Inc. involving a project led by Joshua Werner exploring the recovery and recycling of precious metals. 

Sanitizer to Health Care Workers, Manufacturing Instructions to Spirits Industry

The James B. Beam Institute for Kentucky Spirits is making sanitizer and creating an instructional video for distillers who want to do the same. The multidisciplinary Beam Institute is naturally suited for projects of this nature, with experts in biotechnology, chemistry and engineering.

Independent Stave Company and Boswell Family Give $1 Million for Spirits Maturation Warehouse at UK

The gift will fund a maturation facility that will allow the Beam Institute to experiment with barrel aging spirits produced in its research distillery.

Filter News